BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

627 related articles for article (PubMed ID: 34117116)

  • 21. Evaluating clinical effectiveness of SARS-CoV-2 vaccine in solid organ transplant recipients: A propensity score matched analysis.
    Tucker M; Azar MM; Cohen E; Gan G; Deng Y; Foppiano Palacios C; Malinis M
    Transpl Infect Dis; 2022 Aug; 24(4):e13876. PubMed ID: 35684932
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The solid organ transplant recipient with SARS-CoV-2 infection.
    Laracy JC; Miko BA; Pereira MR
    Curr Opin Organ Transplant; 2021 Aug; 26(4):412-418. PubMed ID: 34074938
    [TBL] [Abstract][Full Text] [Related]  

  • 23. COVID-19 infection among autoimmune rheumatic disease patients: Data from an observational study and literature review.
    Bakasis AD; Mavragani CP; Boki KA; Tzioufas AG; Vlachoyiannopoulos PG; Stergiou IE; Skopouli FN; Moutsopoulos HM
    J Autoimmun; 2021 Sep; 123():102687. PubMed ID: 34311142
    [TBL] [Abstract][Full Text] [Related]  

  • 24. COVID-19 and kidney transplantation: Results from the TANGO International Transplant Consortium.
    Cravedi P; Mothi SS; Azzi Y; Haverly M; Farouk SS; Pérez-Sáez MJ; Redondo-Pachón MD; Murphy B; Florman S; Cyrino LG; Grafals M; Venkataraman S; Cheng XS; Wang AX; Zaza G; Ranghino A; Furian L; Manrique J; Maggiore U; Gandolfini I; Agrawal N; Patel H; Akalin E; Riella LV
    Am J Transplant; 2020 Nov; 20(11):3140-3148. PubMed ID: 32649791
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of severe acute respiratory syndrome coronavirus 2 monoclonal antibodies in high-risk solid organ transplant recipients across three major coronavirus disease 2019 variant waves.
    Zeitler K; Piccicacco N; O'Neal M; Montero J; Myers A; Strebig D; Nestler S; Anger LB; Kim K
    Transpl Infect Dis; 2023 Aug; 25(4):e14095. PubMed ID: 37378536
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of antibody responses after COVID-19 vaccination in liver transplant recipients and those with chronic liver diseases.
    Thuluvath PJ; Robarts P; Chauhan M
    J Hepatol; 2021 Dec; 75(6):1434-1439. PubMed ID: 34454993
    [TBL] [Abstract][Full Text] [Related]  

  • 27. COVID-19 pneumonia in kidney transplant recipients: Focus on immunosuppression management.
    Chen TY; Farghaly S; Cham S; Tatem LL; Sin JH; Rauda R; Ribisi M; Sumrani N
    Transpl Infect Dis; 2020 Oct; 22(5):e13378. PubMed ID: 32573882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of COVID-19 in solid organ transplant recipients.
    Danziger-Isakov L; Blumberg EA; Manuel O; Sester M
    Am J Transplant; 2021 Mar; 21(3):925-937. PubMed ID: 33319449
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of donor and recipient Epstein-Barr Virus serostatus on outcomes of allogeneic hematopoietic cell transplantation: a systematic review and meta-analysis.
    Kołodziejczak M; Gil L; de la Camara R; Styczyński J;
    Ann Hematol; 2021 Mar; 100(3):763-777. PubMed ID: 33491135
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immune Response after the Fourth Dose of SARS-CoV-2 mRNA Vaccine Compared to Natural Infection in Three Doses' Vaccinated Solid Organ Transplant Recipients.
    Busà R; Russelli G; Miele M; Sorrentino MC; Di Bella M; Timoneri F; Di Mento G; Mularoni A; Vitulo P; Conaldi PG; Bulati M
    Viruses; 2022 Oct; 14(10):. PubMed ID: 36298854
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical Effects of COVID-19 on Hematopoietic Stem Cell Transplant Outcomes in Pediatric Patients.
    Barhoom D; Mohseni R; Hamidieh AA; Mohammadpour M; Sharifzadeh M; Navaeian A; Taebi S; Behfar M
    Exp Clin Transplant; 2021 May; 19(5):501-507. PubMed ID: 34053422
    [TBL] [Abstract][Full Text] [Related]  

  • 32. COVID-19 in solid organ transplant recipients: Dynamics of disease progression and inflammatory markers in ICU and non-ICU admitted patients.
    Roberts MB; Izzy S; Tahir Z; Al Jarrah A; Fishman JA; El Khoury J
    Transpl Infect Dis; 2020 Oct; 22(5):e13407. PubMed ID: 32654303
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical outcomes and serologic response in solid organ transplant recipients with COVID-19: A case series from the United States.
    Fung M; Chiu CY; DeVoe C; Doernberg SB; Schwartz BS; Langelier C; Henrich TJ; Yokoe D; Davis J; Hays SR; Chandran S; Kukreja J; Ng D; Prostko J; Taylor R; Reyes K; Bainbridge E; Bond A; Chin-Hong P; Babik JM
    Am J Transplant; 2020 Nov; 20(11):3225-3233. PubMed ID: 32476258
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early administration of SARS-CoV-2 monoclonal antibody reduces the risk of mortality in hematologic malignancy and hematopoietic cell transplant patients with COVID-19.
    Jabr R; Khatri A; Anderson AD; Garcia LC; Viotti JB; Natori Y; Raja M; Camargo JF; Morris MI
    Transpl Infect Dis; 2023 Feb; 25(1):e14006. PubMed ID: 36704987
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunology of Transplant Patients with SARS-CoV-2 Infection: Transmission, Immune Response, and Therapeutic Strategy.
    Wang M; Zhao Y; Wei L; Chen D; Yang B; Chen Z
    Crit Rev Immunol; 2020; 40(6):475-484. PubMed ID: 33900692
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Covid-19 in liver transplant recipients: the French SOT COVID registry.
    Dumortier J; Duvoux C; Roux O; Altieri M; Barraud H; Besch C; Caillard S; Coilly A; Conti F; Dharancy S; Durand F; Francoz C; Garaix F; Houssel-Debry P; Kounis I; Lassailly G; Laverdure N; Leroy V; Mallet M; Mazzola A; Meunier L; Radenne S; Richardet JP; Vanlemmens C; Hazzan M; Saliba F; ;
    Clin Res Hepatol Gastroenterol; 2021 Jul; 45(4):101639. PubMed ID: 33636654
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of immunocompromised COVID-19 patients with convalescent plasma.
    Fung M; Nambiar A; Pandey S; Aldrich JM; Teraoka J; Freise C; Roberts J; Chandran S; Hays SR; Bainbridge E; DeVoe C; Roque Gardner A; Yokoe D; Henrich TJ; Babik JM; Chin-Hong P
    Transpl Infect Dis; 2021 Apr; 23(2):e13477. PubMed ID: 32989856
    [TBL] [Abstract][Full Text] [Related]  

  • 38. COVID-19 in solid organ transplant recipients: A systematic review and meta-analysis of current literature.
    Raja MA; Mendoza MA; Villavicencio A; Anjan S; Reynolds JM; Kittipibul V; Fernandez A; Guerra G; Camargo JF; Simkins J; Morris MI; Abbo LA; Natori Y
    Transplant Rev (Orlando); 2021 Jan; 35(1):100588. PubMed ID: 33246166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcome of COVID-19 in liver transplant recipients: A preliminary report from Northwestern Italy.
    Patrono D; Lupo F; Canta F; Mazza E; Mirabella S; Corcione S; Tandoi F; De Rosa FG; Romagnoli R
    Transpl Infect Dis; 2020 Oct; 22(5):e13353. PubMed ID: 32500942
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immune reconstitution and severity of COVID-19 among hematopoietic cell transplant recipients.
    Malek AE; Adachi JA; Mulanovich VE; Sassine J; Raad II; McConn K; Seiler GT; Dhal U; Khawaja F; Chemaly RF
    Transpl Infect Dis; 2021 Aug; 23(4):e13606. PubMed ID: 33755273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.